The Food and Drug Administration said it is investigating the possible increased risk of stroke, heart attack and death in men who are taking testosterone-boosting products for the condition widely called "low-T.". The drugs are approved by the agency for men with low levels of the male hormone for medical reasons such as genetic problems or chemotherapy. But they are widely prescribed for "off-label" use (or uses not specifically approved by the agency), mostly for older men seeking to boost their flagging...
  